New study to monitor MenQuadfi® vaccine safety in thousands
NCT ID NCT07621653
First seen Jun 05, 2026 · Last updated Jun 10, 2026 · Updated 1 time
Summary
This study is checking the safety of the MenQuadfi® vaccine, which protects against four types of meningococcal disease. About 706 healthy people aged 6 weeks to 55 years in South Korea will be watched for side effects after getting the vaccine in regular clinics. The goal is to find any unexpected or rare reactions not seen in earlier trials.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MENINGOCOCCAL IMMUNIZATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.